Companies: 10,795·Total market cap: $144.5T
Nkarta, Inc.

Nkarta, Inc.

NKTXNASDAQHealthcare● Active
$2.47
+$0.07(+2.71%)
Market Cap$176359307
P/E Ratio
52W High$3.65
52W Low$1.63
Overview

Nkarta, Inc. (NKTX) · Income Statement

Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.

FMP · NKTX · as of 2026-06-09

Financial statements

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$0.00B$0.00B$0.00B$0.00B$0.00B
Cost of Revenue$0.01B$0.00B$0.01B$0.00B$0.00B
Gross Profit($0.01B)$0.00B($0.01B)$0.00B$0.00B
Gross Margin %(computed)
Operating Expenses
R&D Expenses$0.09B$0.10B$0.09B$0.09B$0.06B
G&A Expenses$0.03B$0.03B$0.03B$0.03B$0.02B
Total Operating Expenses$0.11B$0.13B$0.13B$0.12B$0.09B
Operating Income($0.12B)($0.13B)($0.13B)($0.12B)($0.09B)
Operating Margin %(computed)
Interest Income$0.02B$0.02B$0.01B$0.01B$0.00B
Interest Expense$0.00B$0.00B$0.00B$0.01B$0.00B
Income Before Tax($0.10B)($0.11B)($0.12B)($0.11B)($0.09B)
Income Tax Expense$0.00B$0.00B$0.00B$0.00B$0.00B
Net Income($0.10B)($0.11B)($0.12B)($0.11B)($0.09B)
Net Margin %(computed)
Per Share & EBITDA
EPS (Basic)$-1.41$-1.60$-2.40$-2.61$-2.62
Wtd Avg Shares0.07B0.07B0.05B0.04B0.03B
EBITDA($0.11B)($0.12B)($0.12B)($0.12B)($0.08B)
EBITDA Margin %(computed)

Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · B

Explore more Nkarta, Inc. data

About Nkarta, Inc. (NKTX) Income Statement

Nkarta, Inc. (NKTX) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, NKTX reported revenue of $0.00B, gross profit of ($0.01B) (gross margin —), and net income of ($0.10B) — a net profit margin of —.

Frequently asked questions

NKTX · 4 questions

Nkarta, Inc. (NKTX) reported revenue of $0.00B for 2025, down —% year-over-year.

NKTX revenueNKTX salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09